Entry Detail



General Information

Database ID:exR0089877
RNA Name:hsa-miR-424-5p
RNA Type:miRNA
Chromosome:chrX
Starnd:-
Coordinate:
Start Site(bp):134546680End Site(bp):134546701
External Links:hsa-miR-424-5p



Disease Information

Disease Name:Preterm Birth
Disease Category:Urogenital Diseases and Pregnancy Complications
MeSH ID:D047928
Type:Diseases Category/Female Urogenital Diseases and Pregnancy Complications
Alias:Premature Birth//Birth, Premature//Births, Premature//Premature Births//Preterm Birth//Birth, Preterm//Births, Preterm//Preterm Births



Expression Detail

GEO ID:GSE106224
Description:Exosomal RNA may reflect placenta deficiencies and provide better biomarker in preterm birth
Experimental Design:Disease vs Control
Case Disease Type:Preterm Birth
Case Disease SubType:NA
Case Sample:Preterm Birth
Control Sample:Control
Number of Case:20
Number of Control:50
Number of Samples:70





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
AADAT
chr4
170060222
170091699
-
ARRDC4
chr15
97960703
97973833
+
ASB1
chr2
238426742
238452250
+
ATXN2L
chr16
28823035
28837237
+
BACE1
chr11
117285207
117316259
-
CASZ1
chr1
10636604
10796650
-
DCAF7
chr17
63550477
63594279
+
FAM102B
chr1
108560089
108644900
+
FLOT2
chr17
28879335
28897733
-
JADE2
chr5
134524312
134583230
+
KDSR
chr18
63327726
63367228
-
LITAF
chr16
11547722
11636381
-
LY6E
chr8
143017982
143023832
+
MAPKBP1
chr15
41774434
41827855
+
MED11
chr17
4731428
4733607
+
MINDY2
chr15
58771192
58861900
+
MRPS2
chr9
135499984
135504673
+
MYB
chr6
135181308
135219173
+
PRKAA1
chr5
40759379
40798374
-
RAPGEF1
chr9
131576770
131740074
-
RET
chr10
43077064
43130351
+
RTL8B
chrX
135020513
135022542
-
STEAP3
chr2
119223831
119265652
+
TOB2
chr22
41433494
41446801
-
ZNF664
chr12
123971845
124015439
+
miRNA targets:NA
circRNA targets:
circRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
hsa_circ_0000540
chr14
55799534
55821940
+
hsa_circ_0001005
chr2
53921020
53978078
-
hsa_circ_0001723
chr7
91924202
91948826
+
hsa_circ_0000458
chr12
124071293
124074996
+
hsa_circ_0001699
chr7
40027197
40041630
+
hsa_circ_0001387
chr4
1902352
1936989
+
hsa_circ_0001168
chr20
47691321
47707559
+
hsa_circ_0000552
chr14
71880664
71948928
+
hsa_circ_0000038
chr1
28800065
28802803
+
hsa_circ_0000652
chr15
90984737
90986710
+
hsa_circ_0001472
chr5
36953719
36976504
+
hsa_circ_0001263
chr3
5215701
5216099
+
hsa_circ_0000799
chr17
65941524
65972074
+
hsa_circ_0001164
chr20
45891031
45923523
-
hsa_circ_0000032
chr1
25666964
25669564
+
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
NUTM2A-AS1
chr10
87201647
87342612
-
LINC02035
chr3
122886941
122892416
+
AC002470.2
chr22
20979462
20998121
+
AC021092.1
chr19
44103007
44113183
-
MCM3AP-AS1
chr21
46229196
46259390
+
LINC00662
chr19
27681072
27794005
-
MIR503HG
chrX
134543119
134546642
-
MIR497HG
chr17
7015818
7019659
-
AC079781.5
chr7
97851688
97972985
-
STAG3L5P-PVRIG2P-PILRB
chr7
100336104
100367831
+
SNHG12
chr1
28578538
28583132
-
AC009022.1
chr16
69976297
70065948
-
LINC00649
chr21
33915534
33977691
+
AP000317.2
chr21
34073592
34360033
+
AL359924.1
chr1
237862175
237928321
+
AC114980.1
chr5
93860669
93863825
-
FGD5-AS1
chr3
14920347
14948424
-
AL031282.2
chr1
1702736
1737688
-
NUTM2B-AS1
chr10
79661394
79826594
-
AL391244.1
chr1
1420245
1422691
+
LINC01184
chr5
127939152
128083172
-
XIST
chrX
73820649
73852723
-
HCG18
chr6
30286690
30327382
-
SNHG16
chr17
76557764
76565348
+
SNHG25
chr17
64145970
64146476
+
SNHG1
chr11
62851984
62855953
-
AC020978.7
chr16
68224713
68227734
+
MZF1-AS1
chr19
58559129
58574797
+
MIR29B2CHG
chr1
207801518
207879115
-
AC003092.1
chr7
94022833
94066661
+
Display:



Experiment Detail

GEO ID:GSE106224
Sample Source:Blood
Source Fraction:Plasma
Platform:GPL18573
Method:NGS
Num of detected RNA Type:1
Num of detected RNAs of this Type:1522
Sample treatment protocol:Whole blood samples were centrifuged for 15 minutes at 2,000×g at 4°C to get plasma. EVs were isolated from 100 ul of plasma using size exclusion columns (iZON qEV, Cambridge MA) with de-gassed 1X PBS from a total of 22 selected samples, 11 from each group (Table 1). Eluate (~500 ul for each fraction) was collected in microfuge tubes individually. The protein contains and concentration for each fraction were assessed by protein gel electrophoresis and Bradford assay (BioRad, Hercules, CA).
RNA Extract protocol:RNA was isolated from all plasma samples, the 22 EV samples, and 22 corresponding EV-depleted fractions using miRNeasy Micro Kit (Qiagne, Germantown MD).
RNA library preparation protocol:Small RNA sequencing libraries were generated with a modified small RNAseq protocol (manuscript in preparation) that alleviates most of the adapter-miRNA ligation sequence bias problem.



Reference

PMID:29516617
Title:Extracellular vesicle RNAs reflect placenta dysfunction and are a biomarker source for preterm labour
Author:Fallen S, Baxter D, Wu X, Kim TK, Shynlova O, Lee MY, Scherler K, Lye S, Hood L, Wang K
Journal:J Cell Mol Med. 2018 May;22(5):2760-2773.
Description:We have used an improved small RNA library construction protocol and a newly developed size exclusion chromatography (SEC)-based EV purification method to gain a comprehensive view of circulating RNA in plasma and its distribution by analysing RNAs in whole plasma and EV-associated and EV-depleted plasma.